SEHK:1066Medical Equipment
Weigao Group (SEHK:1066) Margin Compression Reinforces Bearish Narratives Despite Stable Revenue
Shandong Weigao Group Medical Polymer (SEHK:1066) has reported FY 2025 results with second half revenue of C¥6.7b and basic EPS of C¥0.13, while trailing twelve month revenue came in at C¥13.4b and EPS at C¥0.36. The company has seen half year revenue move from C¥6.5b in 2H 2024 to C¥6.6b in 1H 2025 and C¥6.7b in 2H 2025, with basic EPS at C¥0.21, C¥0.22 and C¥0.13 across those same periods. With a trailing net profit margin of 12% against a higher margin a year earlier, the latest numbers...